Literature DB >> 19471162

The genomic applications in practice and prevention network.

Muin J Khoury1, W Gregory Feero, Michele Reyes, Toby Citrin, Andrew Freedman, Debra Leonard, Wylie Burke, Ralph Coates, Robert T Croyle, Karen Edwards, Sharon Kardia, Colleen McBride, Teri Manolio, Gurvaneet Randhawa, Rebekah Rasooly, Jeannette St Pierre, Sharon Terry.   

Abstract

The authors describe the rationale and initial development of a new collaborative initiative, the Genomic Applications in Practice and Prevention Network. The network convened by the Centers for Disease Control and Prevention and the National Institutes of Health includes multiple stakeholders from academia, government, health care, public health, industry and consumers. The premise of Genomic Applications in Practice and Prevention Network is that there is an unaddressed chasm between gene discoveries and demonstration of their clinical validity and utility. This chasm is due to the lack of readily accessible information about the utility of most genomic applications and the lack of necessary knowledge by consumers and providers to implement what is known. The mission of Genomic Applications in Practice and Prevention Network is to accelerate and streamline the effective integration of validated genomic knowledge into the practice of medicine and public health, by empowering and sponsoring research, evaluating research findings, and disseminating high quality information on candidate genomic applications in practice and prevention. Genomic Applications in Practice and Prevention Network will develop a process that links ongoing collection of information on candidate genomic applications to four crucial domains: (1) knowledge synthesis and dissemination for new and existing technologies, and the identification of knowledge gaps, (2) a robust evidence-based recommendation development process, (3) translation research to evaluate validity, utility and impact in the real world and how to disseminate and implement recommended genomic applications, and (4) programs to enhance practice, education, and surveillance.

Entities:  

Mesh:

Year:  2009        PMID: 19471162      PMCID: PMC2743616          DOI: 10.1097/GIM.0b013e3181a551cc

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  21 in total

1.  How good is the quality of health care in the United States? 1998.

Authors:  Mark A Schuster; Elizabeth A McGlynn; Robert H Brook
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

2.  Keeping pace with the times--the Genetic Information Nondiscrimination Act of 2008.

Authors:  Kathy L Hudson; M K Holohan; Francis S Collins
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

Review 3.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Authors:  Heidi D Nelson; Laurie Hoyt Huffman; Rongwei Fu; Emily L Harris
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

4.  US system of oversight for genetic testing: a report from the Secretary's Advisory Committee on Genetics, Health and Society.

Authors:  Andrea Ferreira-Gonzalez; Steven Teutsch; Marc S Williams; Sylvia M Au; Kevin T Fitzgerald; Paul Steven Miller; Cathy Fomous
Journal:  Per Med       Date:  2008-09-01       Impact factor: 2.512

5.  Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

Review 6.  The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?

Authors:  Muin J Khoury; Marta Gwinn; Paula W Yoon; Nicole Dowling; Cynthia A Moore; Linda Bradley
Journal:  Genet Med       Date:  2007-10       Impact factor: 8.822

7.  Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer.

Authors:  Chanita Hughes Halbert; Lisa Kessler; Jill E Stopfer; Susan Domchek; E Paul Wileyto
Journal:  Genet Med       Date:  2006-09       Impact factor: 8.822

8.  Genetic testing for susceptibility to breast and ovarian cancer: evaluating the impact of a direct-to-consumer marketing campaign on physicians' knowledge and practices.

Authors:  Melanie F Myers; Man-Huei Chang; Cynthia Jorgensen; William Whitworth; Sidibe Kassim; James A Litch; Lori Armstrong; Barbara Bernhardt; W Andrew Faucett; Debra Irwin; Judy Mouchawar; Linda A Bradley
Journal:  Genet Med       Date:  2006-06       Impact factor: 8.822

9.  Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

10.  Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

View more
  22 in total

1.  Personalized therapeutics: a potential threat to health equity.

Authors:  Michael M Ward
Journal:  J Gen Intern Med       Date:  2012-02-07       Impact factor: 5.128

2.  Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility.

Authors:  Christopher A Cassa; Sarah K Savage; Patrick L Taylor; Robert C Green; Amy L McGuire; Kenneth D Mandl
Journal:  Genome Res       Date:  2012-01-06       Impact factor: 9.043

3.  A genetic test registry: bringing credible and actionable data together.

Authors:  M J Khoury; M Reyes; M Gwinn; W G Feero
Journal:  Public Health Genomics       Date:  2009-11-26       Impact factor: 2.000

4.  Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?

Authors:  Caroline Fiona Wright; Mark Kroese
Journal:  Hum Genet       Date:  2009-11-20       Impact factor: 4.132

5.  Participation in genetic testing research varies by social group.

Authors:  Sharon Hensley Alford; Colleen M McBride; Robert J Reid; Eric B Larson; Andreas D Baxevanis; Lawrence C Brody
Journal:  Public Health Genomics       Date:  2010-03-18       Impact factor: 2.000

6.  Using Public-Private Partnerships to Mitigate Disparities in Access to Genetic Services: Lessons from Wisconsin.

Authors:  Laura Senier; Matthew Kearney; Jason Orne
Journal:  Adv Med Sociol       Date:  2015

7.  The challenge of implementing genetic tests with clinical utility while avoiding unsound applications.

Authors:  Martina C Cornel; Carla G van El; Pascal Borry
Journal:  J Community Genet       Date:  2012-10-09

Review 8.  Risk factors for autism: translating genomic discoveries into diagnostics.

Authors:  Stephen W Scherer; Geraldine Dawson
Journal:  Hum Genet       Date:  2011-06-24       Impact factor: 4.132

9.  Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.

Authors:  Andrew N Freedman; Leah B Sansbury; William D Figg; Arnold L Potosky; Sheila R Weiss Smith; Muin J Khoury; Stefanie A Nelson; Richard M Weinshilboum; Mark J Ratain; Howard L McLeod; Robert S Epstein; Geoffrey S Ginsburg; Richard L Schilsky; Geoffrey Liu; David A Flockhart; Cornelia M Ulrich; Robert L Davis; Lawrence J Lesko; Issam Zineh; Gurvaneet Randhawa; Christine B Ambrosone; Mary V Relling; Nat Rothman; Heng Xie; Margaret R Spitz; Rachel Ballard-Barbash; James H Doroshow; Lori M Minasian
Journal:  J Natl Cancer Inst       Date:  2010-10-13       Impact factor: 13.506

10.  Development and evaluation of a genetic risk score for obesity.

Authors:  Daniel W Belsky; Terrie E Moffitt; Karen Sugden; Benjamin Williams; Renate Houts; Jeanette McCarthy; Avshalom Caspi
Journal:  Biodemography Soc Biol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.